Guangji Pharmaceutical announced that the application documents for the company's 2026 issuance of shares to specific targets were accepted by the Shenzhen Stock Exchange on August 26, 2026, and the application documents are complete. The matter still needs to be reviewed by the Shenzhen Stock Exchange and approved by the China Securities Regulatory Commission before it can be implemented.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.